COVID-19 Antiviral Pill Therapy

StarMed Healthcare is now offering an antiviral pill therapy to treat patients with mild-to-moderate COVID-19 symptoms. It is the first pill offered to treat the virus and is most effective when taken within five days of being exposed to or diagnosed with COVID-19.

We are proud to provide both Monlupiravir (Merck) and Paxlovid (Pfizer) to our patients.

COVID-19 Pre-exposure Prevention with Evusheld

U.S. Food and Drug Administration issued an emergency use authorization (EUA) for AstraZeneca’s Evusheld for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and pediatric individuals.

Click the button above to register now.